HUE049939T2 - Liposzómák vírusfertõzések kezelésére - Google Patents
Liposzómák vírusfertõzések kezeléséreInfo
- Publication number
- HUE049939T2 HUE049939T2 HUE17731852A HUE17731852A HUE049939T2 HU E049939 T2 HUE049939 T2 HU E049939T2 HU E17731852 A HUE17731852 A HU E17731852A HU E17731852 A HUE17731852 A HU E17731852A HU E049939 T2 HUE049939 T2 HU E049939T2
- Authority
- HU
- Hungary
- Prior art keywords
- liposomes
- treatment
- viral infections
- infections
- viral
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/688—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pulmonology (AREA)
- Dispersion Chemistry (AREA)
- Biotechnology (AREA)
- Inorganic Chemistry (AREA)
- Otolaryngology (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16174700 | 2016-06-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE049939T2 true HUE049939T2 (hu) | 2020-11-30 |
Family
ID=56134203
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE17731852A HUE049939T2 (hu) | 2016-06-16 | 2017-06-15 | Liposzómák vírusfertõzések kezelésére |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20190328663A1 (hu) |
| EP (1) | EP3471732B1 (hu) |
| DK (1) | DK3471732T3 (hu) |
| ES (1) | ES2811025T3 (hu) |
| HR (1) | HRP20201257T1 (hu) |
| HU (1) | HUE049939T2 (hu) |
| LT (1) | LT3471732T (hu) |
| PL (1) | PL3471732T3 (hu) |
| PT (1) | PT3471732T (hu) |
| RS (1) | RS60602B1 (hu) |
| SI (1) | SI3471732T1 (hu) |
| WO (1) | WO2017216282A1 (hu) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20170000875A1 (en) | 2013-12-02 | 2017-01-05 | Arytha Biosciences, Llc | Toxoid preparation and uses thereof |
| CN111971068A (zh) * | 2018-04-20 | 2020-11-20 | 康柏辛股份有限公司 | 败血症和败血性休克的治疗 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8889398B2 (en) * | 2006-05-19 | 2014-11-18 | Viroblock Sa | Composition for inactivating an enveloped virus |
| CN109549925B (zh) | 2012-06-14 | 2022-06-17 | 伯尔尼大学 | 用于治疗细菌感染的定制脂质体 |
-
2017
- 2017-06-15 US US16/310,319 patent/US20190328663A1/en not_active Abandoned
- 2017-06-15 EP EP17731852.4A patent/EP3471732B1/en active Active
- 2017-06-15 HU HUE17731852A patent/HUE049939T2/hu unknown
- 2017-06-15 RS RS20200872A patent/RS60602B1/sr unknown
- 2017-06-15 WO PCT/EP2017/064653 patent/WO2017216282A1/en unknown
- 2017-06-15 SI SI201730343T patent/SI3471732T1/sl unknown
- 2017-06-15 DK DK17731852.4T patent/DK3471732T3/da active
- 2017-06-15 ES ES17731852T patent/ES2811025T3/es active Active
- 2017-06-15 LT LTEP17731852.4T patent/LT3471732T/lt unknown
- 2017-06-15 PL PL17731852T patent/PL3471732T3/pl unknown
- 2017-06-15 PT PT177318524T patent/PT3471732T/pt unknown
-
2020
- 2020-08-11 HR HRP20201257TT patent/HRP20201257T1/hr unknown
-
2022
- 2022-09-20 US US17/948,713 patent/US20230028179A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| HRP20201257T1 (hr) | 2020-11-13 |
| DK3471732T3 (da) | 2020-08-17 |
| US20230028179A1 (en) | 2023-01-26 |
| SI3471732T1 (sl) | 2020-09-30 |
| EP3471732A1 (en) | 2019-04-24 |
| WO2017216282A1 (en) | 2017-12-21 |
| PT3471732T (pt) | 2020-08-24 |
| EP3471732B1 (en) | 2020-05-13 |
| US20190328663A1 (en) | 2019-10-31 |
| ES2811025T3 (es) | 2021-03-10 |
| RS60602B1 (sr) | 2020-08-31 |
| PL3471732T3 (pl) | 2020-10-19 |
| LT3471732T (lt) | 2020-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL263972A (en) | Dihydropyranopyrimidines for the treatment of viral infections | |
| HK1225968A1 (zh) | 用於治療hbv感染的組合療法 | |
| ZA201708039B (en) | Adenoassociated virus vectors for the treatment of mucopolysaccharidoses | |
| HK1216421A1 (zh) | 用於治療病毒感染的治療化合物 | |
| ZA201900156B (en) | Phosphoramidates for the treatment of hepatitis b virus | |
| EP3233878A4 (en) | PHOSPHORAMIDATE FOR THE TREATMENT OF HEPATITIS C VIRUS | |
| SG11201609652RA (en) | Treatment of polybacterials infections | |
| HK1258276A1 (zh) | 用於治療hiv的化合物和組合 | |
| PT3519569T (pt) | Vetores de vírus adenoassociados para o tratamento de mucopolissacaridoses | |
| IL256327A (en) | Pharmacological preparations for the treatment of viral problems of the eye | |
| HK1252343A1 (zh) | 用於治療病毒感染的組合物和方法 | |
| HK1257272A1 (zh) | 治療hiv的工具 | |
| ZA201902385B (en) | Compounds and methods for diagnosis and treatment of viral infections | |
| HK1247558A1 (zh) | 塞內可瑞偉洛克(cenicriviroc)用於治療纖維化 | |
| PL3471732T3 (pl) | Liposomy do leczenia infekcji wirusowych | |
| RS60451B1 (sr) | Novi postupci za dobijanje vemurafeniba | |
| EP3448377A4 (en) | METHODS FOR THE TREATMENT OF AN INFECTION | |
| PL3095866T3 (pl) | Środek do profilaktyki i terapii infekcji wirusowych | |
| SG10202010317VA (en) | Pyrimidine prodrugs for the treatment of viral infections and further diseases | |
| SG11201703330YA (en) | Iminosugars useful for the treatment of viral diseases | |
| PT3166604T (pt) | Agentes para o tratamento de doenças infeciosas retrovirais | |
| PL3131890T3 (pl) | Związki do leczenia zakażeń wirusowych | |
| GB201619704D0 (en) | Treatment of pathogenic infections |